Cargando…

CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?

Chimeric antigen receptor T-cell (CAR-T) therapy has been prosperous in the treatment of patients with various types of relapsed/refractory (R/R) B-cell malignancies including diffuse large B-cell lymphoma (DLBCL), B-cell acute lymphoblastic leukemia (B-ALL), follicular lymphoma (FL), mantle cell ly...

Descripción completa

Detalles Bibliográficos
Autores principales:	Safarzadeh Kozani, Pouya, Safarzadeh Kozani, Pooria, Rahbarizadeh, Fatemeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499460/ https://www.ncbi.nlm.nih.gov/pubmed/34620233 http://dx.doi.org/10.1186/s13287-021-02595-0

Ejemplares similares

Novel antigens of CAR T cell therapy: New roads; old destination
por: Safarzadeh Kozani, Pooria, et al.
Publicado: (2021)

Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
por: Safarzadeh Kozani, Pouya, et al.
Publicado: (2021)

Strategies for Dodging the Obstacles in CAR T Cell Therapy
por: Safarzadeh Kozani, Pooria, et al.
Publicado: (2021)

Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia
por: Hashem Boroojerdi, Mohadese, et al.
Publicado: (2020)

Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero?
por: Safarzadeh Kozani, Pouya, et al.
Publicado: (2022)

Humanized Chimeric Antigen Receptor (CAR) T cells
por: Kozani, Pouya Safarzadeh, et al.
Publicado: (2021)

Nanobody-based CAR-T cells for cancer immunotherapy
por: Safarzadeh Kozani, Pouya, et al.
Publicado: (2022)

T-cells engineered with a novel VHH-based chimeric antigen receptor against CD19 exhibit comparable tumoricidal efficacy to their FMC63-based counterparts
por: Nasiri, Fatemeh, et al.
Publicado: (2023)

AS1411-functionalized delivery nanosystems for targeted cancer therapy
por: Kozani, Pooria Safarzadeh, et al.
Publicado: (2021)

CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil
por: Nasiri, Fatemeh, et al.
Publicado: (2022)

Marine Bacteria versus Microalgae: Who Is the Best for Biotechnological Production of Bioactive Compounds with Antioxidant Properties and Other Biological Applications?
por: Hamidi, Masoud, et al.
Publicado: (2019)

Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
por: Dabiri, Hamed, et al.
Publicado: (2023)

New cell sources for CAR-based immunotherapy
por: Mazinani, Marzieh, et al.
Publicado: (2023)

CAR-T cell potency: from structural elements to vector backbone components
por: Mazinani, Marzieh, et al.
Publicado: (2022)

Vitamin D Review: The Low Hanging Fruit for Human Health
por: Mungai, Lucy N. W., et al.
Publicado: (2021)

Chimeric antigen receptor T (CAR‐T) cells: Novel cell therapy for hematological malignancies
por: Abbasi, Samane, et al.
Publicado: (2022)

The sweet branch of metabolic engineering: cherry-picking the low-hanging sugary fruits
por: Chen, Rachel
Publicado: (2015)

The Prevalence of Iron Deficiency in Atrial Fibrillation: Low Hanging Fruit?
por: Alabdullah, Bachar, et al.
Publicado: (2022)

Vaccines for older adults; the low-hanging fruit of disease prevention
por: Wennekes, MD, et al.
Publicado: (2022)

CAR T-Cell Therapy in Hematological Malignancies
por: Haslauer, Theresa, et al.
Publicado: (2021)

192. More Low-hanging Fruit: Antibiotic Chelation Drug Interactions
por: Kenney, Rachel M, et al.
Publicado: (2018)

3D hanging spheroid plate for high-throughput CAR T cell cytotoxicity assay
por: Chen, Zhenzhong, et al.
Publicado: (2022)

Picking the low-hanging fruit: testing new physics at scale with active learning
por: Rocamonde, Juan, et al.
Publicado: (2022)

Best practices in treatment of urinary tract infections (UTIs): “low-hanging fruit”
Publicado: (2019)

Spinoculation and retronectin highly enhance the gene transduction efficiency of Mucin-1-specific chimeric antigen receptor (CAR) in human primary T cells
por: Rajabzadeh, Alireza, et al.
Publicado: (2021)

Current Progress in CAR-T Cell Therapy for Hematological Malignancies
por: Han, Donglei, et al.
Publicado: (2021)

Anti-Mesothelin CAR T cell therapy for malignant mesothelioma
por: Castelletti, Laura, et al.
Publicado: (2021)

CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success
por: Long, Kristen B., et al.
Publicado: (2018)

Immunization review meetings: “Low Hanging Fruit” for capacity building and data quality improvement?
por: Shimp, Lora, et al.
Publicado: (2017)

CAR T Cell Therapy for Chronic Lymphocytic Leukemia: Successes and Shortcomings
por: Todorovic, Zeljko, et al.
Publicado: (2022)

The application of CAR-T cell therapy in hematological malignancies: advantages and challenges
por: Zhao, Zijun, et al.
Publicado: (2018)

Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies
por: Wang, Hao, et al.
Publicado: (2019)

2204. Excess Antibiotic Therapy for 5 Common Conditions in Primary Care: Low-Hanging Fruit for Outpatient Antibiotic Stewardship
por: Patel, Payal K, et al.
Publicado: (2023)

The Application of CAR-T Cells in Haematological Malignancies
por: Skorka, Katarzyna, et al.
Publicado: (2020)

The journey of CAR-T therapy in hematological malignancies
por: Lu, Junru, et al.
Publicado: (2022)

CAR T-Cell Therapy: On the Verge of Breakthrough in Many Hematologic Malignancies
por: Stadtmauer, Edward, et al.
Publicado: (2017)

CAR-T cell therapy for hematological malignancies: History, status and promise
por: Wang, Chao, et al.
Publicado: (2023)

Potential strategies against resistance to CAR T-cell therapy in haematological malignancies
por: Cai, Qing, et al.
Publicado: (2020)

Clinical Strategies for Enhancing the Efficacy of CAR T-Cell Therapy for Hematological Malignancies
por: Liu, Qianzhen, et al.
Publicado: (2022)

SUN-280 Sulfonylurea-Responsive Neonatal Diabetes: A Low Hanging Fruit That Has yet to Be Picked?
por: Paulo, Remberto, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_imijmp7je2feim9m2tdda6l6b5